Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jan;44(1):57-62.
doi: 10.1128/AAC.44.1.57-62.2000.

In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi

Affiliations

In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi

S Tawara et al. Antimicrob Agents Chemother. 2000 Jan.

Abstract

The in vitro antifungal activity and spectrum of FK463 were compared with those of amphotericin B, fluconazole, and itraconazole by using a broth microdilution method specified by National Committee for Clinical Laboratory Standards document M27-A (National Committee for Clinical Laboratory Standards, Wayne, Pa., 1997). FK463 exhibited broad-spectrum activity against clinically important pathogens including Candida species (MIC range, <==0.0039 to 2 microg/ml) and Aspergillus species (MIC range, <==0.0039 to 0.0313 microg/ml), and its MICs for such fungi were lower than those of the other antifungal agents tested. FK463 was also potently active against azole-resistant Candida albicans as well as azole-susceptible strains, and there was no cross-resistance with azoles. FK463 showed fungicidal activity against C. albicans, i.e., a 99% reduction in viability after a 24-h exposure at concentrations above 0.0156 microg/ml. The minimum fungicidal concentration (MFC) assays indicated that FK463 was fungicidal against most isolates of Candida species. In contrast, the MFCs of FK463 for A. fumigatus isolates were much higher than the MICs, indicating that its action is fungistatic against this species. FK463 had no activity against Cryptococcus neoformans, Trichosporon species, or Fusarium solani. Neither the test medium (kind and pH) nor the inoculum size greatly affected the MICs of FK463, while the addition of 4% human serum albumin increased the MICs for Candida species and A. fumigatus more than 32 times. Results from preclinical in vitro evaluations performed thus far indicate that FK463 should be a potent parenteral antifungal agent.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Chemical structure of FK463.
FIG. 2
FIG. 2
Fungicidal activity against C. albicans FP633 after a 24-h exposure. The number of viable organisms was determined at 24 h after the addition of compounds by plate counts. Δlog CFU, logarithm of CFU after 24 h of exposure − logarithm of CFU at time zero. ●, FK463; ▴, AMPH-B; ■, FLCZ; ⧫, ITCZ.

References

    1. Abruzzo G K, Flattery A M, Gill C J, Kong L, Smith J G, Pikounis V B, Balkovec J M, Bouffard A F, Dropinski J F, Rosen H, Kropp H, Bartizal K. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother. 1997;41:2333–2338. - PMC - PubMed
    1. Bartizal K, Gill C J, Abruzzo G K, Flattery A M, Kong L, Scott P M, Smith J G, Leighton C E, Bouffard A, Dropinski J F, Balkovec J M. Antimicrob. Agents Chemother. 1997;41:2326–2332. - PMC - PubMed
    1. Bartizal K, Scott T, Abruzzo G K, Gill C J, Pacholok C, Lynch L, Kropp H. In vitro evaluation of the pneumocandin antifungal agent L-733,560, a new water-soluble hybrid of L-705,589 and L-731,373. Antimicrob Agents Chemother. 1995;39:1070–1076. - PMC - PubMed
    1. Beaulieu D, Tang J, Zeckner D J, Parr T R., Jr Correlation of cilofungin in vivo efficacy with its activity against Aspergillus fumigatus (1,3)-β-d-glucan synthase. FEMS Microbiol Lett. 1993;108:133–138. - PubMed
    1. Debono M, Gordee R S. Antibiotics that inhibit fungal cell wall development. Annu Rev Microbiol. 1994;48:471–497. - PubMed